Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses

Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection

Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model

Dendritic cell immunotherapy in uterine cancer

Novel dendritic cell-based vaccination in late stage melanoma

Dendritic cell-based vaccines: clinical applications in breast cancer

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function

Immunotherapy and lung cancer: current developments and novel targeted therapies

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine